Figure 9 illustrates the SHAP-based feature importance derived from XGB regression models for predicting NF-κB1 normalized counts in the four hematological malignancy groups: AML, MPN, MDS, and PCN. The gene discussed is NFKB1; the disease is myeloproliferative disorder.